Stroke trials in South Africa
2 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Cape Town, Johannesburg, Paarl, Sommerset West, Worcester
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - No phaseTaking peopleNeurovascular Product Surveillance Registry
- Where
- Johannesburg
- Age
- 18 years and over
- People
- 4,000 worldwide
- Run by
- Medtronic Neurovascular Clinical Affairs
See details and how to joinNCT02988128